Moldàvia - romanès - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

krka d.d., novo mesto - esomeprazolum - capsule gastrorezistente - 40 mg

Moldàvia - romanès - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zentiva k.s. - esomeprazolum - capsule gastrorezistente - 40 mg

Unió Europea - romanès - EMA (European Medicines Agency)

shionogi b.v. - naldemedine tosilate - constipație - medicamente pentru constipație, periferice antagoniști ai receptorilor opioizi - rizmoic este indicat pentru tratamentul constipației induse de opioide (oic) la pacienții adulți care au fost tratați anterior cu un laxativ.

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

astrazeneca ab - suedia - combinatii (naproxen + esomeprazol) - compr. elib. modif. - 500mg/20mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

astrazeneca ab - suedia - combinatii (naproxenum+esomeprazolum) - compr. cu elib. modif. - 500mg/20mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

generics [uk] ltd. - omeprazolum - caps. gastrorez. - 20mg - med. pt. trat. ulcerului gastro-duodenal si bolii-reflux g.e inhibitori ai pompei protonice

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

generics [uk] ltd. - omeprazolum - caps. gastrorez. - 40mg - med. pt. trat. ulcerului gastro-duodenal si bolii-reflux g.e inhibitori ai pompei protonice

Unió Europea - romanès - EMA (European Medicines Agency)

taw pharma (ireland) limited - clopidogrel clorhidrat - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - agenți antitrombotici - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Moldàvia - romanès - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

swiss parenterals pvt.ltd. - esomeprazolum - pulbere pentru soluţie injectabilă/perfuzabilă - 40 mg

Moldàvia - romanès - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zentiva k.s. - esomeprazolum - capsule gastrorezistente - 20 mg